The International Nurses Society of Addictions announces the following webinar:
Opioid Facts and Figures
DATE & TIME
- Friday, June 3
12pm – 1pm ET
(Duration: 1 hour)
- Cost: $0, Free to all Attendees
HOW TO REGISTER
DESCRIPTION
With the increasing prevalence of illicit fentanyl, it is important for healthcare providers to understand the new hurdles they may face in treatment of opioid use disorders. This session aims to improve the healthcare provider’s understanding of the changing trends of illicit opioids that they may see in their patient population. This will provide information on pharmacokinetics and how fentanyl may differ from other opioids and will touch base on treatment modalities..
EDUCATIONAL OBJECTIVES
- Learn the pharmacokinetics of Opioids.
- Learn about the change in trends of illicit opioids.
- Introduction to treatment modalities.
WHO SHOULD ATTEND
This presentation was developed for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators.
PRESENTER
Lauran Wirf, DO: Addiction Medicine Fellow; University of Colorado School of Medicine; Denver, Colorado
Lauran completed her residency in Emergency Medicine at Rush University in Chicago, IL, where she became interested in Addiction Medicine. Dr Wirfs is currently completing her Addiction Medicine Fellowship at the University of Colorado in Denver. Dr. Wirf is enjoying her Addiction Fellowship and she is excited to stay and work in the Denver metro area to practice following the completion of her Fellowship.
NURSING CEs
- This course has been approved by the California Board of Registered Nursing for a maximum of 1.00 Nursing Contact Hour. The licensee must retain this document for a period of four (4) years after the course concludes.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
